Full data view for gene GCDH

Variant classification: please note that where there are several records of the same variant, classification of that variant
may differ between records depending on the reporting publication or the submitter's opinion. For the curator’s opinion on
the classification, please view the SUMMARY record or the concluded functional effect (value in column Effect after the /).
Information The variants shown are described using the NM_000159.3 transcript reference sequence.

7 entries on 1 page. Showing entries 1 - 7.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/+ 2i c.91+5G>A r.spl? p.? Unknown ACMG pathogenic g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 ACMG/ACGS: PS1, PS4_Moderate, PM3, PP3, PM2_Supporting (December 2023) - - - SUMMARY record - - - - - - - - - - - - - - - - - - - - - - -
+?/+ 2i c.91+5G>A r.spl? p.? Both (homozygous) - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta 2021 - - Germline/De novo (untested) - 10/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat18 PubMed: Sitta 2021 - M yes - - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+?/+ 2i c.91+5G>A r.spl? p.? Both (homozygous) - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta 2021 - - Germline/De novo (untested) - 10/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat16 PubMed: Sitta 2021 - M no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+?/+ 2i c.91+5G>A r.spl? p.? Unknown - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta 2021 - - Germline/De novo (untested) - 10/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat13 PubMed: Sitta 2021 neurological symptoms without a defined diagnosis in family F no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+?/+ 2i c.91+5G>A r.spl? p.? Both (homozygous) - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta 2021 - - Germline/De novo (untested) - 10/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat12 PubMed: Sitta 2021 - F no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+?/+ 2i c.91+5G>A r.spl? p.? Unknown - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta 2021 - - Germline/De novo (untested) - 10/48 (alleles) - - - DNA PCR, SEQ dried blood spots - GA1 Pat10 PubMed: Sitta 2021 - M no Brazil - - - - all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
+?/+ 2i c.91+5G>A r.spl? p.? Both (homozygous) - likely pathogenic (recessive) g.13002214G>A g.12891400G>A IVS1+5G>A - GCDH_000277 The effect of splice-site mutation was predicted by means of the Human Splicing Finder v.3.0. PubMed: Sitta2021 - - Germline/De novo (untested) - 10/48 - - - DNA PCR, SEQ dried blood spots - GA1 33064266-Patient 1 PubMed: Sitta2021 - M yes Brazil - - - - Treatment: all patients diagnosed in the authors laboratory were immediately submitted to the available treatment based on protein (lysine) restricted diets and L-carnitine supplementation 1 Sabrina Oeser
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.